Literature DB >> 6305340

Thyroxine action on the rat liver nuclear thyroid-hormone receptors. Binding of thyroxine to the nuclear non-histone protein and induction of mitochondrial alpha-glycerophosphate dehydrogenase activity.

Y Yoshimasa, S Hamada.   

Abstract

The possibility that thyroxine (T4) itself exerts the hormonal effect in vivo on the rat liver nuclear receptor was studied with the aid of iopanoic acid (IOP), an inhibitor of the conversion of T4 into tri-iodothyronine (T3). After administration of 2.4 micrograms of T4/100 g body weight to hypothyroid rats for 7 days, T4 and T3 concentrations in serum and in the liver nuclear non-histone protein (NHP) were all increased to the hyperthyroid range. Hepatic mitochondrial alpha-glycerophosphate dehydrogenase (alpha-GPD) activity and DNA content increased significantly. The equilibrium association constant (Ka) of the nuclear T3 receptor was unchanged and the maximal binding capacity (Cmax.) increased 1.4-fold. Simultaneous administration of IOP (5 mg/100 g body weight) to the rats given 2.4 micrograms of T4/100 g body weight completely blocked the conversion into T3. The serum T4 was even more increased, whereas the serum T3 decreased to the hypothyroid range. Although the NHP-bound T4 was at a concentration comparable with the rats given T4 alone, no NHP-bound T3 was detected. Yet the alpha-GPD activity was elevated 2.8-fold and the DNA content increased to the same extent as observed in the rats given T4 alone. The Ka and Cmax. of the nuclear receptor were significantly decreased. After administration of 48 or 480 micrograms of T4/100 g body weight for 3 days, serum T4 and T3 were markedly increased. The NHP-bound T3 was also increased, but no NHP-bound T4 was detected. The alpha-GPD activity was markedly elevated, but the DNA content was unchanged. The Cmax. per g of liver was increased, whereas the Ka remained unchanged. Simultaneous administration of IOP to these animals could not completely block the T4 conversion. The observed hormonal effects in the absence of nuclear T3 indicate that T4 possesses the intrinsic hormonal activities on the rat liver. T4 is less potent in induction of alpha-GPD activity but as potent in increment of hepatic DNA as T3. Although the binding site for T4 is not fully characterized, it appears to be acidic NHP. T4 is an active hormone, yet is also a prohormone of T3, offering the closest analogy with testosterone.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6305340      PMCID: PMC1154228          DOI: 10.1042/bj2100331

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  29 in total

Review 1.  Active form of the thyroid hormone.

Authors:  S H Ingbar; L E Braverman
Journal:  Annu Rev Med       Date:  1975       Impact factor: 13.739

2.  Binding of selected iodothyronine analogues to receptor sites of isolated rat hepatic nuclei. High correlation between structural requirements for nuclear binding and biological activity.

Authors:  D Koerner; H L Schwartz; M I Surks; J H Oppenheimer
Journal:  J Biol Chem       Date:  1975-08-25       Impact factor: 5.157

3.  Modulation of thyroid hormone nuclear receptor levels by 3,5,3'-triiodo-L-thyronine in GH1 cells. Evidence for two functional components of nuclear-bound receptor and relationship to the induction of growth hormone synthesis.

Authors:  H H Samuels; F Stanley; L E Shapiro
Journal:  J Biol Chem       Date:  1977-09-10       Impact factor: 5.157

Review 4.  Nuclear receptors and the initiation of thyroid hormone action.

Authors:  J H Oppenheimer; H L Schwartz; M I Surks; D Koerner; W H Dillmann
Journal:  Recent Prog Horm Res       Date:  1976

5.  Specific nuclear triiodothyronine binding sites in rat liver and kidney.

Authors:  J H Oppenheimer; D Koerner; H L Schwartz; M I Surks
Journal:  J Clin Endocrinol Metab       Date:  1972-08       Impact factor: 5.958

6.  Limited capacity binding sites for L-triiodothyronine in rat liver nuclei. Localization to the chromatin and partial characterization of the L-triiodothyronine-chromatin complex.

Authors:  M I Surks; D Koerner; W Dillman; J H Oppenheimer
Journal:  J Biol Chem       Date:  1973-10-25       Impact factor: 5.157

7.  Correlation of serum triiodothyronine (T3) and thyroxine (T4) with biologic effects of thyroid hormone replacement in propylthiouracil-treated rats.

Authors:  R D Frumess; P R Larsen
Journal:  Metabolism       Date:  1975-04       Impact factor: 8.694

8.  Reciprocal changes in serum concentrations of 3,3',5-triiodothyronine (T3) in systemic illnesses.

Authors:  I J Chopra; U Chopra; S R Smith; M Reza; D H Solomon
Journal:  J Clin Endocrinol Metab       Date:  1975-12       Impact factor: 5.958

9.  Propylthiouracil inhibits the conversion of L-thyroxine to L-triiodothyronine. An explanation of the antithyroxine effect of propylthiouracil and evidence supporting the concept that triiodothyronine is the active thyroid hormone.

Authors:  J H Oppenheimer; H L Schwartz; M I Surks
Journal:  J Clin Invest       Date:  1972-09       Impact factor: 14.808

10.  Dose-dependent depletion of nuclear receptors by L-triiodothyronine: evidence for a role in induction of growth hormone synthesis in cultured GH1 cells.

Authors:  H H Samuels; F Stanley; L E Shapiro
Journal:  Proc Natl Acad Sci U S A       Date:  1976-11       Impact factor: 11.205

View more
  2 in total

1.  Thyroid hormone-dependent seasonality in American tree sparrows (Spizella arborea): effects of GC-1, a thyroid receptor beta-selective agonist, and of iopanoic acid, a deiodinase inhibitor.

Authors:  M K Mishra; F E Wilson; T S Scanlan; G Chiellini
Journal:  J Comp Physiol B       Date:  2004-07-02       Impact factor: 2.200

2.  2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) as a potent and persistent thyroxine agonist: a mechanistic model for toxicity based on molecular reactivity.

Authors:  J D McKinney; J Fawkes; S Jordan; K Chae; S Oatley; R E Coleman; W Briner
Journal:  Environ Health Perspect       Date:  1985-09       Impact factor: 9.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.